NASDAQ:BHTG

BioHiTech Global Stock Forecast, Price & News

$1.48
+0.01 (+0.68 %)
(As of 09/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.42
$1.52
50-Day Range
$1.19
$1.75
52-Week Range
$1.10
$4.03
Volume209,727 shs
Average Volume1.24 million shs
Market Capitalization$42.04 million
P/E RatioN/A
Dividend YieldN/A
Beta1.28
30 days | 90 days | 365 days | Advanced Chart
Receive BHTG News and Ratings via Email

Sign-up to receive the latest news and ratings for BioHiTech Global and its competitors with MarketBeat's FREE daily newsletter.


BioHiTech Global logo

About BioHiTech Global

BioHiTech Global, Inc. engages in the provision of waste management services. Its products and services include food waste digesters, data analytics tools, traditional disposal services, and sophisticated facilities for processing municipal solid waste. The company was founded on March 20, 2013 and is headquartered in New York, NY.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.04 out of 5 stars

Business Services Sector

146th out of 391 stocks

Educational Services Industry

18th out of 50 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











BioHiTech Global (NASDAQ:BHTG) Frequently Asked Questions

Is BioHiTech Global a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BioHiTech Global in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" BioHiTech Global stock.
View analyst ratings for BioHiTech Global
or view top-rated stocks.

What stocks does MarketBeat like better than BioHiTech Global?

Wall Street analysts have given BioHiTech Global a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but BioHiTech Global wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting BioHiTech Global?

BioHiTech Global saw a increase in short interest in August. As of August 13th, there was short interest totaling 1,430,000 shares, an increase of 80.2% from the July 29th total of 793,400 shares. Based on an average daily volume of 681,000 shares, the days-to-cover ratio is presently 2.1 days. Approximately 6.0% of the company's stock are sold short.
View BioHiTech Global's Short Interest
.

When is BioHiTech Global's next earnings date?

BioHiTech Global is scheduled to release its next quarterly earnings announcement on Thursday, November 18th 2021.
View our earnings forecast for BioHiTech Global
.

How were BioHiTech Global's earnings last quarter?

BioHiTech Global, Inc. (NASDAQ:BHTG) announced its quarterly earnings data on Sunday, August, 8th. The company reported ($0.09) EPS for the quarter, missing analysts' consensus estimates of ($0.07) by $0.02. The business had revenue of $3.46 million for the quarter, compared to the consensus estimate of $3.18 million. BioHiTech Global had a negative net margin of 105.89% and a negative trailing twelve-month return on equity of 1,047.13%.
View BioHiTech Global's earnings history
.

How has BioHiTech Global's stock been impacted by Coronavirus?

BioHiTech Global's stock was trading at $1.71 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BHTG stock has decreased by 13.5% and is now trading at $1.48.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for BHTG?

1 analysts have issued 12 month target prices for BioHiTech Global's stock. Their forecasts range from $4.00 to $4.00. On average, they expect BioHiTech Global's stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 170.3% from the stock's current price.
View analysts' price targets for BioHiTech Global
or view top-rated stocks among Wall Street analysts.

Who are BioHiTech Global's key executives?

BioHiTech Global's management team includes the following people:
  • Anthony Fuller, Chief Executive Officer & Director
  • Robert A. Joyce, President & Chief Operating Officer
  • Brian C. Essman, Treasurer, Chief Financial & Accounting Officer
  • Richard Galterio, Executive VP & Investor Relations Contact
  • Dennis Soriano, Director-Business Development

Who are some of BioHiTech Global's key competitors?

What other stocks do shareholders of BioHiTech Global own?

What is BioHiTech Global's stock symbol?

BioHiTech Global trades on the NASDAQ under the ticker symbol "BHTG."

Who are BioHiTech Global's major shareholders?

BioHiTech Global's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (3.00%), Renaissance Technologies LLC (1.11%), Geode Capital Management LLC (0.72%), Gabelli Funds LLC (0.12%) and State Street Corp (0.09%). Company insiders that own BioHiTech Global stock include Frank E Celli, James D Chambers and Robert A Joyce.
View institutional ownership trends for BioHiTech Global
.

Which major investors are selling BioHiTech Global stock?

BHTG stock was sold by a variety of institutional investors in the last quarter, including Gabelli Funds LLC.
View insider buying and selling activity for BioHiTech Global
or view top insider-selling stocks.

Which major investors are buying BioHiTech Global stock?

BHTG stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Renaissance Technologies LLC, Geode Capital Management LLC, and State Street Corp. Company insiders that have bought BioHiTech Global stock in the last two years include Frank E Celli, James D Chambers, and Robert A Joyce.
View insider buying and selling activity for BioHiTech Global
or or view top insider-buying stocks.

How do I buy shares of BioHiTech Global?

Shares of BHTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BioHiTech Global's stock price today?

One share of BHTG stock can currently be purchased for approximately $1.48.

How much money does BioHiTech Global make?

BioHiTech Global has a market capitalization of $42.04 million and generates $5.88 million in revenue each year. The company earns $-11,540,000.00 in net income (profit) each year or ($0.62) on an earnings per share basis.

How many employees does BioHiTech Global have?

BioHiTech Global employs 42 workers across the globe.

What is BioHiTech Global's official website?

The official website for BioHiTech Global is www.biohitech.com.

Where are BioHiTech Global's headquarters?

BioHiTech Global is headquartered at 80 RED SCHOOLHOUSE ROAD SUITE 101, CHESTNUT RIDGE NY, 10977.

How can I contact BioHiTech Global?

BioHiTech Global's mailing address is 80 RED SCHOOLHOUSE ROAD SUITE 101, CHESTNUT RIDGE NY, 10977. The company can be reached via phone at (845) 262-1081 or via email at [email protected]


This page was last updated on 9/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.